NewsBenzinga摩根大通维持对雅诗兰黛公司的“增持”评级，将目标价上调至120美元 摩根大通维持对雅诗兰黛公司的“增持”评级，将目标价上调至120美元 Benzinga 2026.11.03 18:04 (GMT+0) Open on Benzinga Other news Piper Sandler Maintains Neutral on RxSight, Lowers Price Target to $8 RBC Capital Reiterates Outperform on Shopify, Maintains $200 Price Target Piper Sandler Maintains Underweight on Innovative Ind Props, Raises Price Target to $46 Piper Sandler Maintains Neutral on Atlas Energy Solutions, Lowers Price Target to $13 RBC Capital Maintains Sector Perform on Safehold, Lowers Price Target to $12 Zimmer Biomet Lifts Annual Growth Despite Challenging Knee Market
